Argenica Therapeutics Ltd
ASX:AGN
Argenica Therapeutics Ltd
ASX:AGN
Price:
0.18
AUD
9.09%
Market Closed
Market Cap:
AU$23.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Argenica Therapeutics Ltd
ASX:AGN
|
AU |
|
Z
|
Zinzino AB
STO:ZZ B
|
SE |
|
Four Seasons Education (Cayman) Inc
NYSE:FEDU
|
CN |
|
Gbt Technologies Inc
OTC:GTCH
|
US |
|
Secure Energy Services Inc
TSX:SES
|
CA |
|
Great Eastern Holdings Ltd
SGX:G07
|
SG |
|
S
|
Shristi Infrastructure Development Corporation Ltd
BSE:511411
|
IN |
|
Godrej Industries Ltd
NSE:GODREJIND
|
IN |
|
L
|
LGMS Bhd
KLSE:LGMS
|
MY |
|
Chongqing Zaisheng Technology Co Ltd
SSE:603601
|
CN |
|
K
|
Kwangmu Co Ltd
KOSDAQ:029480
|
KR |
Balance Sheet
Balance Sheet Decomposition
Argenica Therapeutics Ltd
Argenica Therapeutics Ltd
Balance Sheet Decomposition is not available for
Argenica Therapeutics Ltd
Argenica Therapeutics Ltd
Balance Sheet
Argenica Therapeutics Ltd
Argenica Therapeutics Ltd
Currency: AUD
| Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
7
|
9
|
9
|
16
|
11
|
|
| Cash |
0
|
7
|
9
|
9
|
16
|
11
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
7
|
9
|
10
|
16
|
11
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
7
+1 825%
|
9
+24%
|
10
+6%
|
16
+72%
|
11
-33%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
2
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
0
|
0
|
1
|
2
|
2
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+18%
|
1
+73%
|
2
+155%
|
2
+29%
|
4
+57%
|
|
| Equity | |||||||
| Common Stock |
0
|
8
|
13
|
17
|
28
|
30
|
|
| Retained Earnings |
0
|
1
|
5
|
9
|
14
|
22
|
|
| Total Equity |
0
N/A
|
7
+37 111%
|
8
+21%
|
8
-8%
|
14
+82%
|
7
-48%
|
|
| Total Liabilities & Equity |
0
N/A
|
7
+1 825%
|
9
+24%
|
10
+6%
|
16
+72%
|
11
-33%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
73
|
73
|
87
|
98
|
124
|
128
|
|
Switch to:
Switch to:
See Also
Discover More
